Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de Geoffrey Schuyler Crouse
Leeftijd : 50
Vermogen : 822 499 USD
Belangrijkste bedrijven : Invitae Corporation - Syneron Medical Ltd.
Overzicht 
Currently, Geoffrey Schuyler Crouse holds the position of Chief Executive Officer at Syneron Medical Ltd., Chief Executive Officer for Candela Corp. (a subsidiary of Syneron Medical Ltd.) and Chief Executive Officer at Candela Medical. Mr. Crouse is also on the board of Invitae Corp., California Cryobank LLC, Generate Life Sciences Co. and Syneron Candela (UK) Ltd.

He previously held the position of Chief Operating Officer at Immucor, Inc., Chief Executive Officer at CBR Systems, Inc., Vice President-Life Sciences Business at EMD Millipore Corp., Director-Market Development at Roche Diagnostics Corp. and Executive Vice President for AMAG Pharmaceuticals, Inc.

Geoffrey Schuyler Crouse received a graduate degree and an MBA from the University of California, Berkeley and an undergraduate degree from Boston College.


Posities en verantwoordelijkheden van Geoffrey Schuyler Crouse 
NaamTitel Van
Invitae Corporation
(Biotechnologie & Medisch Onderzoek)
Independent Director 2012
Syneron Medical Ltd.
(Medische apparatuur, benodigdheden & distributie)
Chief Executive Officer 2017
Candela Corp. Chief Executive Officer -
Candela Medical Chief Executive Officer -
California Cryobank LLC Director 2018
Generate Life Sciences Co. Director -
Syneron Candela (UK) Ltd. Director 2017


Belangnemingen van Geoffrey Schuyler Crouse 
NaamAandelen%Totale waarde
Invitae Corporation (NVTA)
(Biotechnologie & Medisch Onderzoek)
27 7590,013%822 499 USD


Geoffrey Schuyler CrousePersoonlijk netwerk 
Meest gelezen nieuws 
15/09BRAD SMITH : Microsoft kondigt inkoop van eigen aandelen aan tot $60 mrd, verhoogt dividend
MR
13/09MARTIN SORRELL : Sorrell's S4 Capital verhoogt winstverwachting tot 40%
MR
21:58WILLIAM ACKMAN : Ackman's Pershing Square fonds stijgt bij beursdebuut Universal
MR
14/09STEPHEN SCHERR : Goldman Sachs benoemt Coleman als nieuwe CFO, ter vervanging van Scherr
MR
15/09ILHAM KADRI : Activist Bluebell Capital wil ontslag CEO Solvay
AM
Meer nieuws


© 2021 People and Ownership :   
Geoffrey Schuyler Crouse Verbindingen